A unanimous California jury has found Monsanto/Bayer liable for failing to warn that its weed killer, Roundup, could cause cancer. The federal jury awarded the plaintiff, Ed Hardeman, $80 million in the first bellwether trial of this vastly growing litigation, striking a blow to Monsanto and opening the door for thousands of individuals whose lives have been adversely affected by the development of Non-Hodgkin's Lymphoma as a result of Roundup usage. Specifically, the jury awarded Hardeman $200,967 in economic damages, approximately $5 million in future and past noneconomic damages, and $75 million in punitive damages.This was a bifurcated trial in which the jury heard a causation phase and a secondary damages phase. The causation phase of the trial ended on March 19 when the jury concluded that Roundup was a substantial factor in causing Hardeman's cancer, sending the dispute into a second phase to determine liability and damages. During the damages phase, the jury heard evidence that between 1980 and 2012, Monsanto was aware of five epidemiological studies, seven animal studies, three oxidative stress studies and 14 genotoxicity studies that linked its Roundup products to cancer. Mr. Hardeman's lawyers argued that despite the studies, Monsanto never warned consumers and refused to conduct its own long-term research.Monsanto executives were also accused of "ghostwriting" multiple academic articles in the 1990s and 2000s, allegedly in an effort to mislead federal regulators and the public about the safety of Roundup. Mr. Hardeman's attorneys asked the jury to award punitive damages against Monsanto for "manipulating the science" and public opinion for years, pointing out that Bayer bought Monsanto for $63 billion in June, and Monsanto made $210 million from Roundup sales in one year alone.